Your browser doesn't support javascript.
Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine.
Karron, Ruth A; Key, Nigel S; Sharfstein, Joshua M.
  • Karron RA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
  • Key NS; Department of Medicine, University of North Carolina at Chapel Hill.
  • Sharfstein JM; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
JAMA ; 325(24): 2445-2447, 2021 06 22.
Article in English | MEDLINE | ID: covidwho-1208328
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sinus Thrombosis, Intracranial / Thrombocytopenia / Ebola Vaccines / Ebolavirus Topics: Vaccines Limits: Humans Language: English Journal: JAMA Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sinus Thrombosis, Intracranial / Thrombocytopenia / Ebola Vaccines / Ebolavirus Topics: Vaccines Limits: Humans Language: English Journal: JAMA Year: 2021 Document Type: Article